Cellular localization, invasion, and turnover are differently influenced by healthy and tumor-derived extracellular matrix

Tissue Engineering - Part A

Volumn 20, Issue 13-14, 2014, Pages 2005-2018

  Genovese, Luca ^a,b   Zawada, Lidia ^c   Tosoni, Antonella ^c   Ferri, Angelita ^c   Zerbi, Pietro ^c   Allevi, Raffaele ^d   Nebuloni, Manuela ^c   Alfano, Massimo ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CELLS; DISEASES; DRUG PRODUCTS; ENZYME INHIBITION; HISTOLOGY; POLARIZATION; SOAPS (DETERGENTS); TISSUE HOMEOSTASIS;

ANTINEOPLASTIC DRUGS; CELL PROLIFERATION AND DEATH; CELLULAR LOCALIZATION; COLORECTAL CARCINOMA; EXTRACELLULAR MATRICES; HYPERTONIC SOLUTIONS; NONIONIC DETERGENTS; THREE DIMENSIONAL (3D) STRUCTURES;

TUMORS;

DETERGENT; ENDONUCLEASE; GLYCOPROTEIN; HYPERTONIC SOLUTION; HYALURONIC ACID;

ARTICLE; CELL DEATH; CELL INVASION; CELL METABOLISM; CELLULAR DISTRIBUTION; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STROMA; CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELL TRANSFORMATION; COLORECTAL TUMOR; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; STROMA CELL; TUMOR CELL LINE; TUMOR INVASION;

CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; HYALURONIC ACID; INTESTINAL MUCOSA; MONOCYTES; NEOPLASM INVASIVENESS; STROMAL CELLS;

EID: 84904206041     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0588     Document Type: Article

References (56)

1. Flaumenhaft, R., and Rifkin, D.B. Extracellular matrix regulation of growth factor and protease activity. Curr Opin Cell Biol 3, 817, 1991.
2. Schultz, G.S., and Wysocki, A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 17, 153, 2009.
3. Hynes, R.O. The extracellular matrix: not just pretty fibrils. Science 326, 1216, 2009.
4. Hassell, J.R., Blochberger, T.C., Rada, J.A., Chakravarti, S., and Noonan, D. Proteoglycan gene families. Extracellular Matrix. In: Kleinman, H.K., ed. Advances in Molecular and Cellular Biology. Greenwich, CT: JAI Press, 1993, Vol. 6, pp. 69-113.
5. Fuster, M.M., and Esko, J.D. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5, 526, 2005.
6. Angeli, F., Koumakis, G., Chen, M.C., Kumar, S., and Delinassios, J.G. Role of stromal fibroblasts in cancer: promoting or impeding? Tumour Biol 30, 109, 2009.
7. Caporale, A., Vestri, A.R., Benvenuto, E., Mariotti, M., Cosenza, U.M., Scarpini, M., et al. Is desmoplasia a protective factor for survival in patients with colorectal carcinoma? Clin Gastroenterol Hepatol 3, 370, 2005.
8. Halvorsen, T.B., and Seim, E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 42, 162, 1989.
9. Miura, S., Kodaira, S., and Hosoda, Y. Immunohistologic analysis of the extracellular matrix components of the fibrous stroma of human colon cancer. J Surg Oncol 53, 36, 1993.
10. Arrowsmith, J. Trial watch: Phase II failures: 2008-2010. Nat Rev Drug Discov 10, 328, 2011.
11. Serebriiskii, I., Castello-Cros, R., Lamb, A., Golemis, E.A., and Cukierman, E. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol 27, 573, 2008.
12. Beacham, D.A., Amatangelo, M.D., and Cukierman, E. Preparation of extracellular matrices produced by cultured and primary fibroblasts. Curr Protoc Cell Biol Chapter 10, Unit 10.9, 2007.
13. Labianca, R., Beretta, G.D., Kildani, B., Milesi, L., Merlin, F., Mosconi, S., et al. Colon cancer. Crit Rev Oncol Hematol 74, 106, 2010.
14. Alfano, M., Mariani, S.A., Elia, C., Pardi, R., Blasi, F., and Poli, G. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. Blood 113, 1699, 2009.
15. Spina, M., Ortolani, F., El Messlemani, A., Gandaglia, A., Bujan, J., Garcia-Honduvilla, N., et al. Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: extracellular matrix structure, prevention from calcification, and cell repopulation features. J Biomed Mater Res A 67, 1338, 2003.
16. Yang, Q., Peng, J., Guo, Q., Huang, J., Zhang, L., Yao, J., et al. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Biomaterials 29, 2378, 2008.
17. Castello-Cros, R., and Cukierman, E. Stromagenesis during tumorigenesis: characterization of tumor-associated fibroblasts and stroma-derived 3D matrices. Methods Mol Biol 522, 275, 2009.
18. Crapo, P.M., Gilbert, T.W., and Badylak, S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 32, 3233, 2011.
19. Nebuloni, M., Zawada, L., Ferri, A., Tosoni, A., Zerbi, P., Resnati, M., et al. HIV-1 Infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression. PLoS One 8, e70606, 2013.
20. Paroni, M., Moalli, F., Nebuloni, M., Pasqualini, F., Bonfield, T., Nonis, A., et al. Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy. J Infect Dis 208, 130, 2013.
21. Schneider, C.A., Rasband, W.S., and Eliceiri, K.W. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671, 2012.
22. OBrien, C.A., Pollett, A., Gallinger, S., and Dick, J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106, 2007.
23. Kumar, V., Abbas, A.K., Fausto, N., and Mitchell, R.N., eds. Chapter 15: Gastrointestinal tract histology. In: Robbins Basic Pathology. Philadelphia, PA: Elsevier Saunders, 2007, p. 579.
24. Sica, A. Role of tumour-associated macrophages in cancerrelated inflammation. Exp Oncol 32, 153, 2010.
25. Fogh, J., Orfeo, T., Tiso, J., and Sharkey, F.E. Establishment of human colon carcinoma lines in nude mice. Exp Cell Biol 47, 136, 1979.
26. Hilgendorf, C., Spahn-Langguth, H., Regardh, C.G., Lipka, E., Amidon, G.L., and Langguth, P. Caco-2 versus Caco-2/ HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89, 63, 2000.
27. Solmi, R., Lauriola, M., Francesconi, M., Martini, D., Voltattorni, M., Ceccarelli, C., et al. Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. BMC Cancer 8, 227, 2008.
28. Reynier, M., Sari, H., dAnglebermes, M., Kye, E.A., and Pasero, L. Differences in lipid characteristics of undifferentiated and enterocytic-differentiated HT29 human colonic cells. Cancer Res 51, 1270, 1991.
29. Lesuffleur, T., Porchet, N., Aubert, J.P., Swallow, D., Gum, J.R., Kim, Y.S., et al. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J Cell Sci 106 (Pt 3), 771, 1993.
30. Cohen, E., Ophir, I., and Shaul, Y.B. Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci 112 (Pt 16), 2657, 1999.
31. Lesuffleur, T., Barbat, A., Dussaulx, E., and Zweibaum, A. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50, 6334, 1990.
32. Drewinko, B., Romsdahl, M.M., Yang, L.Y., Ahearn, M.J., and Trujillo, J.M. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 36, 467, 1976.
33. Agostinelli, E., Belli, F., Dalla Vedova, L., Marra, M., Crateri, P., and Arancia, G. Hyperthermia enhances cytotoxicity of amine oxidase and spermine on drug-resistant LoVo colon adenocarcinoma cells. Int J Oncol 28, 1543, 2006.
34. Boland, C.R., Roberts, J.A., Siddiqui, B., Byrd, J., and Kim, Y.S. Cancer-associated colonic mucin in cultured human tumor cells and athymic (nude) mouse xenografts. Cancer Res 46, 5724, 1986.
35. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., et al. Engineering tumors with 3D scaffolds. Nat Methods 4, 855, 2007.
36. Toole, B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4, 528, 2004.
37. Toole, B.P., Zoltan-Jones, A., Misra, S., and Ghatak, S. Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions. Cells Tissues Organs 179, 66, 2005.
38. Gilbert, T.W., Sellaro, T.L., and Badylak, S.F. Decellularization of tissues and organs. Biomaterials 27, 3675, 2006.
39. Reing, J.E., Brown, B.N., Daly, K.A., Freund, J.M., Gilbert, T.W., Hsiong, S.X., et al. The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials 31, 8626.
40. Lu, P., Weaver, V.M., and Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196, 395, 2012.
41. Naba, A., Hoersch, S., and Hynes, R.O. Towards definition of an ECM parts list: an advance on GO categories. Matrix Biol 31, 371, 2012.
42. Naba, A., Clauser, K.R., Hoersch, S., Liu, H., Carr, S.A., and Hynes, R.O. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 11, M111.014647, 2012.
43. Soreide, K., Janssen, E.A., Korner, H., and Baak, J.P. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. J Pathol 209, 147, 2006.
44. Feng, B., Dong, T.T., Wang, L.L., Zhou, H.M., Zhao, H.C., Dong, F., et al. Colorectal cancer migration and invasion initiated by microRNA-106a. PLoS One 7, e43452, 2012.
45. Ninomiya, I., Nagai, N., Oyama, K., Hayashi, H., Tajima, H., Kitagawa, H., et al. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum. Oncol Rep 28, 777, 2012.
46. Liu, T., Zhou, H., Xia, R., Liao, J.,Wu, C.,Wang, H., et al. Tracking tumor cells in lymphatics in a mice xenograft model by magnetic resonance imaging. Mol Imaging 11, 451, 2012.
47. Zhang, H., Hao, Y., Yang, J., Zhou, Y., Li, J., Yin, S., et al. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2, 554, 2011.
48. Reiter, L.S., Kruithof, E.K., Cajot, J.F., and Sordat, B. The role of the urokinase receptor in extracellular matrix deg- radation by HT29 human colon carcinoma cells. Int J Cancer 53, 444, 1993.
49. Yang, J., Sun, M., Zhang, A., Lv, C., De, W., and Wang, Z. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells. World J Surg Oncol 9, 117, 2011.
50. Sanchez-Tillo, E., de Barrios, O., Siles, L., Amendola, P.G., Darling, D.S., Cuatrecasas, M., et al. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1. Clin Cancer Res 19, 1071, 2013.
51. Mamidipudi, V., Dhillon, N.K., Parman, T., Miller, L.D., Lee, K.C., and Cartwright, C.A. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints. Oncogene 26, 2914, 2007.
52. Folkman, J., and Kalluri, R. Cancer without disease. Nature 427, 787, 2004. (Pubitemid 38297724)
53. Kalluri, R., and Zeisberg, M. Fibroblasts in cancer. Nat Rev Cancer 6, 392, 2006.
54. Hu, M., Yao, J., Cai, L., Bachman, K.E., van den Brule, F., Velculescu, V., et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37, 899, 2005.
55. Polyak, K. Breast cancer: origins and evolution. J Clin Invest 117, 3155, 2007.
56. Medema, J.P., and Vermeulen, L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 474, 318, 2011.